Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Cattran

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Journal of the American Society of Nephrology : JASN|June 17, 2015
Complete and Partial Remission as Surrogate End Points in Membranous NephropathyAliza Thompson, Daniel C Cattran, Melanie Blank, et al.
Kidney International|November 27, 2014
The authors replyNeeraj Dhaun, Christopher O Bellamy, Daniel C Cattran, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 21, 2011
Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapyDaniel C Cattran, Heather N Reich, S Joseph Kim, et al.
Journal of the American Society of Nephrology : JASN|November 6, 2007
Remission of proteinuria improves prognosis in IgA nephropathyHeather N Reich, Stéphan Troyanov, James W Scholey, et al.
Kidney International|January 10, 2014
Utility of renal biopsy in the clinical management of renal diseaseNeeraj Dhaun, Christopher O Bellamy, Daniel C Cattran, et al.
BMC Medical Informatics and Decision Making|September 17, 2020
How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathyAnna R Gagliardi, Heather N Reich, Daniel C Cattran, et al.
Journal of the American Society of Nephrology : JASN|November 1, 2016
Membranous Nephropathy: Quantifying Remission Duration on OutcomeDaniel C Cattran, Esther D Kim, Heather Reich, et al.
Kidney International Reports|November 29, 2023
Focal Segmental Glomerulosclerosis: Assessing the Risk of RelapseStéphan Troyanov, Arenn Jauhal, Heather N Reich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2004
Recurrence of anti-GBM disease 8 years after renal transplantationMukesh Khandelwal, Brendan B McCormick, Ginette Lajoie, et al.
Kidney International|August 26, 2004
Idiopathic membranous nephropathy: definition and relevance of a partial remissionStéphan Troyanov, Catherine A Wall, Judith A Miller, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Journal of the American Society of Nephrology : JASN|June 17, 2015
Complete and Partial Remission as Surrogate End Points in Membranous NephropathyAliza Thompson, Daniel C Cattran, Melanie Blank, et al.
Kidney International|November 27, 2014
The authors replyNeeraj Dhaun, Christopher O Bellamy, Daniel C Cattran, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 21, 2011
Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapyDaniel C Cattran, Heather N Reich, S Joseph Kim, et al.
Journal of the American Society of Nephrology : JASN|November 6, 2007
Remission of proteinuria improves prognosis in IgA nephropathyHeather N Reich, Stéphan Troyanov, James W Scholey, et al.
Kidney International|January 10, 2014
Utility of renal biopsy in the clinical management of renal diseaseNeeraj Dhaun, Christopher O Bellamy, Daniel C Cattran, et al.
BMC Medical Informatics and Decision Making|September 17, 2020
How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathyAnna R Gagliardi, Heather N Reich, Daniel C Cattran, et al.
Journal of the American Society of Nephrology : JASN|November 1, 2016
Membranous Nephropathy: Quantifying Remission Duration on OutcomeDaniel C Cattran, Esther D Kim, Heather Reich, et al.
Kidney International Reports|November 29, 2023
Focal Segmental Glomerulosclerosis: Assessing the Risk of RelapseStéphan Troyanov, Arenn Jauhal, Heather N Reich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2004
Recurrence of anti-GBM disease 8 years after renal transplantationMukesh Khandelwal, Brendan B McCormick, Ginette Lajoie, et al.
Kidney International|August 26, 2004
Idiopathic membranous nephropathy: definition and relevance of a partial remissionStéphan Troyanov, Catherine A Wall, Judith A Miller, et al.
Pageof 11